Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Nov 5 - Nov 10
As of 2026, injectable GHK-Cu is classified Category 2 by the FDA, restricting it from 503A pharmacy compounding
patients with controlled hypertension should discuss monitoring with their physician
Journal of molecular medicine (Berlin, Germany) , 95 (3), 323-333
All MT-2 components synthesised in the USA via solid-phase methodology and verified at 99%+ purity by HPLC and Mass Spectrometry
In Phase 2 detoxification, various enzymes act directly on the toxic substances partially degraded and processed in Phase 1, such as heavy metals and organo-toxins, by binding them with protective compounds, thereby either inactivating the toxins
US$ 21.84
US$ 22.34
US$ 22.19
US$ 24.71
